Durata Therapeutics to Present at Upcoming Investor Conferences
June 17 2014 - 9:00AM
Durata Therapeutics (Nasdaq:DRTX) announced today that members of
the executive team will participate in three upcoming investor
conferences.
Paul R. Edick, Chief Executive Officer, will participate in the
ROTH Resources Corporate Access Day on June 24 in London,
England.
Corey Fishman, Chief Operating Officer and Chief Financial
Officer, will present at the JMP Healthcare Conference on June 24
at 9:30am EDT in New York, New York.
Mr. Fishman will also participate in the Janney Capital Markets
Healthcare Corporate Access Day on June 26 in Boston,
Massachusetts.
About Durata Therapeutics, Inc.
Durata Therapeutics is a pharmaceutical company focused on the
development and commercialization of novel therapeutics for
patients with infectious diseases and acute illnesses. For more
information about the company, visit www.duratatx.com.
Forward-looking Statements
Statements contained in this press release contain
forward-looking statements that involve substantial risks and
uncertainties. All statements, other than statements of historical
facts, contained in this press release, including statements
regarding our strategy, future operations, future financial
position, future revenues, projected costs, prospects, plans and
objectives of management, are forward-looking statements. The words
"anticipate," "believe," "estimate," "expect," "intend," "may,"
"plan," "predict," "project," "target," "potential," "will,"
"would," "could," "should," "continue," and similar expressions are
intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words.
CONTACT: Investor Relations and Public Affairs Contact
Allison Wey
Durata Therapeutics
Vice President, Investor Relations and Public Affairs
(312) 219-7017
awey@duratatx.com
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Aug 2024 to Sep 2024
(MM) (NASDAQ:DRTX)
Historical Stock Chart
From Sep 2023 to Sep 2024